Barely Significant
← all excerpts

Long-term trends in ceftolozane-tazobactam susceptibility among gram-negative pathogens in the United States: a nine-year SMART analysis (2016-2024).

JAC Antimicrob Resist · 2026 · PMC13340461 · PMID 42416888

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantP < 0.001actually significant
NDM carriage among C/T nonsusceptible Enterobacterales was very low, ≤1.3% each year from 2016 to 2021; however, it increased to 4.6% in 2022 and 6.5% in 2023, followed by a reduction to 1.8% in 2024, demonstrating a highly significant increasing trend overall ( P < 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.